SteriPlas Cold Plasma to be presented at EACTS 2023
We look forward to Mr Thomas Schlöglhofer’s presentation at the upcoming European Association for Cardio-Thoracic Surgery (EACTS) conference in Vienna on Fri 6th Oct. Thomas will present, “Cold Atmospheric Plasma Therapy as an Effective Treatment of Left Ventricular Assist Device Driveline Infections” which will feature the advantages of our SteriPlas Cold Plasma medical device for deep LVAD infections treated at the Department of Cardiac Surgery, Medical University of Vienna.
Adtec presents at the LSI today
It was a pleasure to present at the LSI - Life Science Intelligence in Barcelona today. The successes of Adtec Healthcare Ltd and our Premium Cold Plasma medical device, the SteriPlas, were presented to the audience with much interest.
If you would like to know more about our strong clinical efficacy and antibiofilm properties for chronic wounds and infections, send us an email at info@adtecplasma.com
First day at the LSI
An epic start to the first day at LSI - Life Science Intelligence in Barcelona.
It has been a pleasure to interact with professionals sharing the same interest in tackling strains on the global wound care market. The benefits that the clinically proven SteriPlas can bring to significantly reduce bed occupancy, chronic infections and the financial burden rates have been demonstrated.
We look forward to presenting more about this on the 21st Sept and encourage you to meet with us whilst at LSI to learn more about our Premium Cold Plasma medical device for chronic wounds, surgical site infections and medical dermatology conditions.
Day 1 of the EUMS
We're having a great time at the #EUMS2023 conference catching up with friends and connecting with new faces interested in our Cold Plasma for LVAD infection management.
We encourage you to visit us whilst you're here to see our Premium Cold Plasma medical device, the SteriPlas, renowned for its antibiofilm properties.
Life Science Intelligence Conference in Barcelona
Adtec Healthcare Ltd will be presenting at the Life Science Intelligence (LSI) Barcelona from 18-22 September 2023. Our Managing Director, Mary, will be showcasing the successes Adtec Healthcare and the SteriPlas have brought to clinical practices dealing with non-healing chronic wounds burdened with biofilm. Mary’s presentation will be held at 10:35 - 10:44 on September 21st and we encourage you to attend and ask your questions to better learn why we remain the leader of high density Cold Plasma medicine.
We'll be at EUMS 2023!
We’re looking forward to exhibiting at the annual European Mechanical Circulatory Support Summit (EUMS) from 3rd – 6th September in Paris.
Visit us at booth no. 5 and see the SteriPlas Cold Plasma medical device for LVAD infections on demonstration. With the strongest clinical evidence to date and our top reputation, we remain the leader of Cold Plasma medicine and continue to free hospitals and patients from the burden of LVAD infections.
SteriPlas will be presented at the ISMCS 2023
Congratulations to Mr Thomas Schlöglhofer who has been invited to speak at the International Society for Mechanical Circulatory Support Scientific Congress (ISMCS) on Wednesday 1st November 2023.
His presentation, “Cold Atmospheric Plasma for Driveline Infection Treatment” will focus on the benefits of the SteriPlas for LVAD infections.
Our medical device has proven efficacy for the treatment of deep LVAD infections with the presence of biofilm. There is growing interest to use our SteriPlas Cold Plasma for LVAD infections due to its quick ability to destroy bacteria protected within biofilm deep within driveline cavity. This is regardless of the type of bacteria or its resistance profile. As LVAD infections can be healed in as quick as 1 week, it provides stability of the independent system and a better quality of life for patients with LVADs.
For more information about the SteriPlas, our clinical evidence or a free trial at your hospital contact us at info@adtecplasma
Advanced Wound Care Summit 2023
We hope you got to see our presentation at the Advanced Wound Care Summit yesterday. We thoroughly enjoyed explaining the strong benefits of our SteriPlas Cold Plasma for biofilm destruction. If you would like to learn more about our medical device and clinical evidence, send us an email info@adtecplasma.com
Size Does Matter!
Size does matter!
Yes, we do manufacture smaller handheld Cold Plasma devices that have antibacterial efficacy but we do not sell these in the medical field. A quick 2 minute treatment time is respective of being focused on the size of the plasma area created. Small and handheld plasma jet devices feature a 1mm2 treatment area which means antibacterial efficacy is achieved in a very small area for every 2 minutes applied. If the wound is 10cm2, we will leave you to do the maths on how long it will take to treat! This is why we do not sell handheld plasma jet pens as medical devices as they are limited to small and superficial wounds.
The SteriPlas creates a gigantic 12cm2 treatment area which is only possible through the size of the medical device which incorporates a series of crucial components such as the generator and control unit. This means the SteriPlas can cover large wounds and finish treatment in as quick as a single two minute session. Whilst the SteriPlas can treat acute and superficial wounds, it is designed to target deep and complicated wounds with #biofilm.
Deep sternal wounds is a classic example as documented in our clinical evidence.
Leading Cold Plasma medicine with the SteriPlas
The SteriPlas produces a repeatable, reliable, and highly efficacious Cold Plasma that has been proven in clinical trials and studies to destroy bacteria protected deep within biofilm.
Regardless of the resistance profile of bacteria, whether they are Gram-negative or Gram-positive, the physical mode of action of the SteriPlas Cold Plasma ensures the destruction of bacteria at the site of infection. This is particularly beneficial for difficult-to-treat or non-healing wounds such as diabetic foot ulcers, sternal wounds and LVAD infections. Where biofilm typically complicates the treatment options for these infections, the SteriPlas has been shown to fully heal patients even if they were not responding to antibiotic treatment to begin with thus saving limbs and lives.
All of this is achieved with the reputable safety of SteriPlas with no side effects reported.